• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间接药效学模型的特点及其在临床药物反应中的应用。

Characteristics of indirect pharmacodynamic models and applications to clinical drug responses.

作者信息

Sharma A, Jusko W J

机构信息

Department of Pharmaceutics, School of Pharmacy, State University of New York at Buffalo, 14260, USA.

出版信息

Br J Clin Pharmacol. 1998 Mar;45(3):229-39. doi: 10.1046/j.1365-2125.1998.00676.x.

DOI:10.1046/j.1365-2125.1998.00676.x
PMID:9517366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1873365/
Abstract

This review describes four basic physiologic indirect pharmacodynamic response (IDR) models which have been proposed to characterize the pharmacodynamics of drugs that act by indirect mechanisms such as inhibition or stimulation of the production or dissipation of factors controlling the measured effect. The principles underlying IDR models and their response patterns are described. The applicability of these basic IDR models to characterize pharmacodynamic responses of diverse drugs such as inhibition of gastric acid secretion by nizatidine and stimulation of MX protein synthesis by interferon alpha-2a is demonstrated. A list of other uses of these models is provided. These models can be readily extended to accommodate additional complexities such as nonstationary or circadian baselines, equilibration delay, depletion or accumulation of a precursor pool, sigmoidicity, or other mechanisms. Indirect response models which have a logical mechanistic basis account for time-delays in many responses and are widely applicable in clinical pharmacology.

摘要

本综述描述了四种基本的生理间接药效学反应(IDR)模型,这些模型旨在表征通过间接机制起作用的药物的药效学,例如抑制或刺激控制所测效应的因子的产生或消耗。描述了IDR模型的基本原理及其反应模式。证明了这些基本IDR模型在表征多种药物的药效学反应方面的适用性,如尼扎替丁抑制胃酸分泌和α-2a干扰素刺激MX蛋白合成。提供了这些模型的其他用途列表。这些模型可以很容易地扩展以适应其他复杂性,如非平稳或昼夜基线、平衡延迟、前体池的消耗或积累、S形或其他机制。具有逻辑机制基础的间接反应模型解释了许多反应中的时间延迟,并且在临床药理学中广泛适用。

相似文献

1
Characteristics of indirect pharmacodynamic models and applications to clinical drug responses.间接药效学模型的特点及其在临床药物反应中的应用。
Br J Clin Pharmacol. 1998 Mar;45(3):229-39. doi: 10.1046/j.1365-2125.1998.00676.x.
2
Physiologic indirect response models characterize diverse types of pharmacodynamic effects.生理间接反应模型可描述多种类型的药效学效应。
Clin Pharmacol Ther. 1994 Oct;56(4):406-19. doi: 10.1038/clpt.1994.155.
3
Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.从基础到系统药效动力学模型的转变:皮质类固醇的经验教训。
Pharmacol Rev. 2020 Apr;72(2):414-438. doi: 10.1124/pr.119.018101.
4
Moving from basic toward systems pharmacodynamic models.从基础向系统药效动力学模型转变。
J Pharm Sci. 2013 Sep;102(9):2930-40. doi: 10.1002/jps.23590. Epub 2013 May 16.
5
Feedback control indirect response models.反馈控制间接响应模型。
J Pharmacokinet Pharmacodyn. 2016 Aug;43(4):343-58. doi: 10.1007/s10928-016-9479-8. Epub 2016 Jul 9.
6
D-optimal designs for parameter estimation for indirect pharmacodynamic response models.间接药效反应模型的参数估计的 D-最优设计。
J Pharmacokinet Pharmacodyn. 2009 Dec;36(6):523-39. doi: 10.1007/s10928-009-9135-7. Epub 2009 Nov 11.
7
Indirect pharmacodynamic models for responses with multicompartmental distribution or polyexponential disposition.具有多室分布或多指数处置的反应的间接药效学模型。
J Pharmacokinet Pharmacodyn. 2001 Feb;28(1):57-78. doi: 10.1023/a:1011517718990.
8
Role of dosage regimen in controlling indirect pharmacodynamic responses.给药方案在控制间接药效学反应中的作用。
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):45-57. doi: 10.1016/s0169-409x(00)00132-0.
9
Mathematical formalism for the properties of four basic models of indirect pharmacodynamic responses.四种间接药效学反应基本模型性质的数学形式主义。
J Pharmacokinet Biopharm. 1997 Feb;25(1):107-23. doi: 10.1023/a:1025723927981.
10
Indirect pharmacodynamic models for responses with circadian removal.具有昼夜节律去除的反应的间接药效动力学模型。
J Pharmacokinet Pharmacodyn. 2019 Feb;46(1):89-101. doi: 10.1007/s10928-019-09620-z. Epub 2019 Jan 29.

引用本文的文献

1
Gut microbe-derived lactic acid optimizes host energy metabolism during starvation.肠道微生物衍生的乳酸在饥饿期间优化宿主能量代谢。
bioRxiv. 2025 May 28:2025.05.27.656452. doi: 10.1101/2025.05.27.656452.
2
Mechanistic intracellular PK/PD modeling to inform development strategies for small interfering RNA therapeutics.用于指导小干扰RNA疗法开发策略的细胞内作用机制的药代动力学/药效学建模
Mol Ther Nucleic Acids. 2025 Mar 17;36(2):102516. doi: 10.1016/j.omtn.2025.102516. eCollection 2025 Jun 10.
3
Defining preclinical efficacy with the DNAPK inhibitor AZD7648 in combination with olaparib: a minimal systems pharmacokinetic-pharmacodynamic model.用DNA依赖性蛋白激酶(DNAPK)抑制剂AZD7648联合奥拉帕利确定临床前疗效:一个最小系统药代动力学-药效学模型
J Pharmacokinet Pharmacodyn. 2025 Feb 17;52(2):17. doi: 10.1007/s10928-025-09962-x.
4
Safety, Tolerability and Pharmacokinetic-Pharmacodynamic Relationship of NX210c Peptide in Healthy Elderly Volunteers: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study.NX210c肽在健康老年志愿者中的安全性、耐受性及药代动力学-药效学关系:随机、安慰剂对照、双盲、多次递增剂量研究
Neurol Ther. 2025 Feb;14(1):357-377. doi: 10.1007/s40120-024-00691-w. Epub 2024 Dec 21.
5
Pharmacodynamics (PD), Pharmacokinetics (PK) and PK-PD Modeling of NRF2 Activating Dietary Phytochemicals in Cancer Prevention and in Health.NRF2激活型膳食植物化学物质在癌症预防和健康中的药效学(PD)、药代动力学(PK)及PK-PD建模
Curr Pharmacol Rep. 2025;11(1):6. doi: 10.1007/s40495-024-00388-6. Epub 2024 Dec 5.
6
Utility and impact of quantitative pharmacology on dose selection and clinical development of immuno-oncology therapy.定量药理学在免疫肿瘤治疗的剂量选择和临床开发中的作用和影响。
Cancer Chemother Pharmacol. 2024 Apr;93(4):273-293. doi: 10.1007/s00280-024-04643-x. Epub 2024 Mar 2.
7
Reciprocal stabilization of coagulation factor XIII-A and -B subunits is a determinant of plasma FXIII concentration.凝血因子 XIII-A 和 -B 亚基的相互稳定是血浆 FXIII 浓度的决定因素。
Blood. 2024 Feb 1;143(5):444-455. doi: 10.1182/blood.2023022042.
8
The Physiological and Pharmacological Significance of the Circadian Timing of the HPA Axis: A Mathematical Modeling Approach.HPA 轴昼夜节律时间的生理和药理学意义:一种数学建模方法。
J Pharm Sci. 2024 Jan;113(1):33-46. doi: 10.1016/j.xphs.2023.08.005. Epub 2023 Aug 18.
9
A framework for precision "dosing" of mental healthcare services: algorithm development and clinical pilot.精神卫生保健服务精准“剂量”框架:算法开发与临床试点
Int J Ment Health Syst. 2023 Jul 5;17(1):21. doi: 10.1186/s13033-023-00581-y.
10
Teaching computational systems biology with an eye on quantitative systems pharmacology at the undergraduate level: Why do it, who would take it, and what should we teach?在本科阶段着眼于定量系统药理学教授计算系统生物学:为何要这样做,谁会选修这门课程,以及我们应该教些什么?
Front Syst Biol. 2022;2. doi: 10.3389/fsysb.2022.1044281. Epub 2022 Nov 25.

本文引用的文献

1
Characterization of four basic models of indirect pharmacodynamic responses.四种间接药效学反应基本模型的表征
J Pharmacokinet Biopharm. 1996 Dec;24(6):611-35. doi: 10.1007/BF02353483.
2
Dynamic modeling of cortisol reduction after inhaled administration of fluticasone propionate.吸入丙酸氟替卡松后皮质醇降低的动态模型
J Clin Pharmacol. 1996 Oct;36(10):938-41. doi: 10.1002/j.1552-4604.1996.tb04761.x.
3
Third-generation model for corticosteroid pharmacodynamics: roles of glucocorticoid receptor mRNA and tyrosine aminotransferase mRNA in rat liver.皮质类固醇药效学的第三代模型:糖皮质激素受体mRNA和酪氨酸转氨酶mRNA在大鼠肝脏中的作用
J Pharmacokinet Biopharm. 1995 Apr;23(2):163-81. doi: 10.1007/BF02354270.
4
Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration.多次静脉给药后呋塞米耐受性的药效学建模
Clin Pharmacol Ther. 1996 Jul;60(1):75-88. doi: 10.1016/S0009-9236(96)90170-8.
5
Use of an indirect pharmacodynamic stimulation model of MX protein induction to compare in vivo activity of interferon alfa-2a and a polyethylene glycol-modified derivative in healthy subjects.
Clin Pharmacol Ther. 1996 Jun;59(6):636-46. doi: 10.1016/S0009-9236(96)90003-X.
6
Convergence of direct and indirect pharmacodynamic response models.直接和间接药效学反应模型的融合。
J Pharmacokinet Biopharm. 1995 Feb;23(1):5-8; discussion 9-10. doi: 10.1007/BF02353781.
7
Tolrestat pharmacokinetic and pharmacodynamic effects on red blood cell sorbitol levels in normal volunteers and in patients with insulin-dependent diabetes.
Clin Pharmacol Ther. 1995 Dec;58(6):631-40. doi: 10.1016/0009-9236(95)90019-5.
8
Pharmacodynamic modeling of nonsteroidal anti-inflammatory drugs: antipyretic effect of ibuprofen.非甾体抗炎药的药效学建模:布洛芬的解热作用
Clin Pharmacol Ther. 1994 Jan;55(1):87-8. doi: 10.1038/clpt.1994.16.
9
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.基于性别的甲基泼尼松龙药代动力学和药效学效应。
Clin Pharmacol Ther. 1993 Oct;54(4):402-14. doi: 10.1038/clpt.1993.167.
10
Comparison of four basic models of indirect pharmacodynamic responses.四种间接药效学反应基本模型的比较。
J Pharmacokinet Biopharm. 1993 Aug;21(4):457-78. doi: 10.1007/BF01061691.